VERASTEM, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.4 USD | -6.59% |
|
-14.14% | -58.23% |
| May. 28 | RBC Halves Price Target on Verastem to $16 From $32, Maintains Outperform Rating, Speculative Risk Qualifier | MT |
| May. 24 | Top Midday Decliners | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERASTEM, INC. | Bio Therapeutic Drugs | -6.59% | -14.14% | -58.23% | -67.77% | -77.33% | 86.11M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- VSTM Stock
- Charts Verastem, Inc.
- Comparison Chart
